The quality bonus payments tied to CMS' star ratings makes it critical that health plans receive a 4 or better, Jonathan Harding, MD, chief medical officer of the Senior Products Division at Tufts Health Plan, said at the America's Health Insurance Plan's National Conferences on Medicare and Medicaid, and Dual Eligibles Summit in Washington, DC, from September 28 to October 2.
The quality bonus payments tied to CMS’ star ratings makes it critical that health plans receive a 4 or better, Jonathan Harding, MD, chief medical officer of the Senior Products Division at Tufts Health Plan, said at the America’s Health Insurance Plan’s National Conferences on Medicare and Medicaid, and Dual Eligibles Summit in Washington, DC, from September 28 to October 2.
Dr Harding explained that since CMS introduced the bonus payments, Tufts Health Plan has decided to abandon efforts to remain on other rankings and instead focus its efforts on the star rating. While the plan is always striving to get a 5-star rating, it’s critical to be a 4 or higher, so that is where Tufts is focusing energy. Tufts Health Plan received 4.5 stars for its Tufts Medicare Preferred HMO and Senior Care Options based on the CMS star ratings for 2015.
“Our profit margin is less than the star bonus amount,” he said. “So really it’s the difference between survival and not.”
The Healthcare Effectiveness Data and Information Set, known as the HEDIS measures, are the largest set of measures that apply to Medicare, and ones that Tufts Health Plan tends to do well in. The patient experience measures are also a large part of the ratings, Dr Harding explained. But neither of them are particularly difficult for plans to improve upon.
The Health Outcomes Survey metrics are usually the hardest set of measures to move, according to Dr Harding. These measures are influenced by patient self-reported measures and health outcomes.
“Those are very hard to influence … because we have no idea who is going to be surveyed, and so we have to address the whole population,” he said.
Further complicating the measures is the fact that they aren’t in anything close to real time. Patients can be surveyed between 4 and 2 years ago, then that information needs to be reported to get into the star ratings, Dr Harding explained.
“So it’s really hard to move them over a short period of time,” he said. “It really takes forethought and long-term planning.”
Blister Packs May Help Solve Medication Adherence Challenges and Lower Health Care Costs
June 10th 2025Julia Lucaci, PharmD, MS, of Becton, Dickinson and Company, discusses the benefits of blister packaging for chronic medications, advocating for payer incentives to boost medication adherence and improve health outcomes.
Listen
Sequencing CAR T and Bispecifics for Multiple Myeloma: Tyler Sandahl, PharmD
July 8th 2025Tyler Sandahl, PharmD, a clinical pharmacist at Mayo Clinic, explains that sequencing novel multiple myeloma therapies with CAR T-cell therapy is generally prioritized first for eligible patients, while bispecific antibodies are reserved for later lines or for patients unable to tolerate CAR T.
Read More
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Driving Value via Outcomes-Based Pricing and EHR Interoperability: Tyler Sandahl, PharmD
July 7th 2025Tyler Sandahl, PharmD, a clinical pharmacist at Mayo Clinic, discussed the complexities of alternative payment models for chimeric antigen receptor T-cell and bispecific therapies and the need for improved data sharing in cancer care.
Read More
Insurance Gaps Threaten Cancer Treatment Success
July 7th 2025Access to and affordability of immune checkpoint inhibitors, which can be lifesaving if patients receive them on time and under optimal circumstances, continue to top the list of reasons behind outcomes disparities for patients who have private insurance vs those who remain uninsured.
Read More